Becker's Healthcare November 13, 2024
Anti-Kickback Statute and the False Claims Act enforcement is entering a new era — turning away from enforcement of COVID-10 pandemic-era fraud, Law.com reported Nov. 7.
The recent reelection of Donald Trump is unlikely to shift AKS’ role as a major weapon in the Department of Justice’s “arsenal of healthcare fraud enforcement,” the report said. But for life sciences and other health services companies, AKS enforcement is entering a new era.
“As new modalities and forms of finance continue to develop within the industry, the coming years promise to shift the terrain on the compliant marketing and delivery of health services,” the report said. “Industry participants should examine and reinforce their compliance strategies to account for an expected...